PHILIP B. HURLEY, MD

Plain English
This study looked at how a type of neuron, called a leaky integrate-and-fire neuron, can detect sudden changes in sensory information. The researchers found that this neuron can detect a 5% change in input signals within just 20 milliseconds, with very few incorrect detections. This matters because it shows that neurons may have sophisticated ways to process information quickly, rather than just averaging out noise in their signals. Who this helps: This helps scientists studying neuronal function and understanding brain processing, as well as potentially benefiting patients with neurological conditions.

Plain English
This research examined the symptoms that can help distinguish between two types of strokes: ischemic (caused by a blocked blood vessel) and hemorrhagic (caused by bleeding in the brain). The study reviewed data from 60 previous studies involving nearly 12.9 million people, finding that certain symptoms like coma and neck stiffness were linked to a higher chance of hemorrhagic stroke, while symptoms like morning onset and facial weakness were associated with a lower chance. This matters because accurately identifying the type of stroke can lead to better, more targeted treatment for patients. Who this helps: This helps doctors making quick decisions about stroke treatment to ensure better outcomes for patients.

Plain English
This study looked at how well SPECT-CT imaging works compared to MRI for diagnosing complex spine problems. Out of 104 patients, MRI found issues in 58 cases, while SPECT-CT found additional problems in 41 cases but only changed treatment plans for 6 patients. The research shows that SPECT-CT can help identify specific issues in patients with previous spinal surgeries, but MRI remains the main imaging method used. Who this helps: This helps doctors and patients with complex spine issues, especially those who have had spinal surgery.

Plain English
This study looked at how healthcare providers feel about screening and referring patients for cancer clinical trials. Out of 693 providers surveyed, nearly half (49.2%) said they screen all patients for these trials, but most of this screening is done manually, which is slow and complicated. The biggest motivation for offering trials was to provide better treatment options, while the main barrier was the hassle of contracts and paperwork, which makes it hard to open more trials. Who this helps: This benefits cancer patients by potentially increasing their access to clinical trial options.

Plain English
The study focused on improving Equity, Diversity, and Inclusivity (EDI) within the Outcome Measures in Rheumatology (OMERACT) organization. Researchers found that most survey respondents were White (75%) and university-educated (94%), with a significant portion being female (61%) and Christian (42%). This matters because enhancing diversity can lead to better representation and more effective outcomes in rheumatology practices. Who this helps: Patients and healthcare professionals involved in rheumatology.

Plain English
This study explored how various academic fields can come together to address antimicrobial resistance (AMR) in UK agriculture and food systems by creating a collaborative network. Researchers conducted an online survey to gather opinions on the network's focus and priorities, revealing that many respondents wanted to unify different disciplines such as social sciences and mathematics to better tackle AMR issues. This collaboration is important because it can lead to more effective solutions that reduce AMR, lower costs associated with antibiotic use, and minimize environmental contamination. Who this helps: This benefits patients, farmers, doctors, and policymakers involved in health and agriculture.

Plain English
This research focused on creating tiny channels in wood, called nanowood, using common household chemicals. The scientists successfully made these channels so small that they are less than 100 nanometers wide, which is crucial for various applications in science and technology. They also measured how well these channels conducted electricity, confirming their successful creation. This is important because it opens up new possibilities for studying fluids at a very small scale, which can lead to advancements in many fields, including medicine and materials science. Who this helps: This helps researchers and scientists working in nanotechnology and fluid dynamics.

Plain English
This study explored how the COVID-19 pandemic affected the mental health of farmers in the UK, surveying 207 farmers and conducting interviews with mental health support providers. The findings showed that 67% of farmers felt more stressed, 63% felt more anxious, and 38% felt more depressed during the pandemic. These challenges were worsened by loneliness, public misunderstandings, and financial pressures, highlighting the importance of providing ongoing support to improve the mental wellbeing of farming communities. Who this helps: This research helps farmers and mental health support providers.

Plain English
This study looked at how to make cancer treatment trials more inclusive by ensuring they reflect the racial and ethnic diversity of cancer patients. The research involved 62 cancer treatment sites, and results showed that 81% were happy with the assessment process, while 82% found ways to improve their inclusivity. Only two sites provided complete data on patient enrollment by race and ethnicity, highlighting the need for better data collection to address disparities in cancer trial participation. Who this helps: This benefits patients from diverse racial and ethnic backgrounds seeking cancer treatment.

Plain English
This study looked at how effective an online training program was in helping cancer research teams recognize and reduce their implicit biases, which can limit the diversity of participants in clinical trials. Of the 50 cancer programs that took part, almost all (98%) completed the training, and participants improved their knowledge of health disparities and bias reduction strategies by 19%-45% after training. This matters because including a more diverse group of patients in cancer trials can lead to better understanding and treatment for all populations affected by cancer. Who this helps: This helps patients, particularly those from underrepresented racial and ethnic backgrounds.

Plain English
This study examined how using a high-quality rectal hydrogel could improve the effectiveness of radiation therapy for prostate cancer without harming the rectum. The researchers found that with the hydrogel in place, they were able to deliver much higher doses of radiation (up to 112 Gy) to the cancerous areas compared to plans without it, resulting in better treatment coverage (98.5 Gy versus 75.53 Gy). This is important because it could lead to better treatment outcomes for patients while minimizing damage to surrounding healthy tissue. Who this helps: Patients with prostate cancer undergoing radiation therapy.

Plain English
Researchers studied the use of Decipher Biopsy testing to better understand the risk levels in men with localized prostate cancer. They found that among 855 men, those with a high-risk Decipher score were over two and a half times more likely to switch from active surveillance (AS) to more aggressive treatment and nearly three times more likely to experience treatment failure. This is important because it shows that Decipher Biopsy can help doctors make better treatment decisions for patients based on their individual cancer risk. Who this helps: This helps patients with localized prostate cancer and their doctors.

Plain English
This study looked at how using a hydrogel spacer during prostate cancer treatment with brachytherapy (a type of internal radiation) can protect the rectum from radiation damage. The research found that patients who had the hydrogel spacer received significantly lower radiation doses to the rectum, with average doses dropping from 91.67 Gy to 65.31 Gy for the maximum dose and from 75.00 Gy to 53.20 Gy for a lower dose (p < 0.001). This is important because minimizing radiation exposure to the rectum can reduce side effects and improve quality of life for patients. Who this helps: This helps prostate cancer patients undergoing radiation treatment.

Plain English
This study looked at cancer-associated fibroblasts (CAF) in patients with advanced head and neck cancer to see how different types of these fibroblasts affect responses to the immunotherapy drug nivolumab. Researchers found that one group of fibroblasts, called HNCAF-0/3, was linked to better responses to treatment, while another group, HNCAF-1, was associated with reduced immune response. This matters because identifying these subpopulations can help predict which patients will benefit from immunotherapy and inform future treatment strategies. Who this helps: This helps patients undergoing immunotherapy for head and neck cancer.

Plain English
This study looked at the serotonin transporter (a protein that helps control mood) in people with major depressive disorder (MDD) compared to healthy individuals. Researchers found that those with MDD had significantly lower binding of this transporter in certain brain areas, particularly near the brainstem, with a noteworthy finding that three out of ten specific brain regions showed lower levels of serotonin binding. These results are important because they could help improve targeted treatments for depression and other disorders that are related to serotonin. Who this helps: This research benefits patients with depression and healthcare providers developing treatment strategies.

Plain English
This research paper focuses on improving the representation of different racial and ethnic groups in cancer clinical trials. The authors emphasize that more diverse trial participants can lead to better understanding of how different people respond to cancer treatments. They present six key recommendations, like ensuring everyone with cancer has a chance to join trials and fostering partnerships with community leaders to make participation easier. This is important because having a more diverse group in trials leads to better treatment insights for everyone. Who this helps: This helps patients from diverse backgrounds and their healthcare providers.

Plain English
This study looked at a complication called bronchopleural fistula (BPF), which can happen after lung surgery. The researchers used a new method that involved reinforcing stitch repairs with a special material from pigs and a hydrogel sealant to successfully close the fistula in a man who had surgery for lung cancer. This approach is promising because it is easier to use and less damaging to a patient’s own tissues, and it could lead to better recovery outcomes. Who this helps: Patients recovering from lung surgery who face complications.

Plain English
This study looked at two patients who developed paralysis of the diaphragm after having COVID-19, which didn’t get better with regular treatments. Both patients underwent a special surgery using robotic assistance to tighten their diaphragm, reinforced with a unique material from cows, and they both experienced significant improvements in breathing and tiredness. This is important because it shows a new effective treatment option for people suffering from diaphragm problems after COVID-19. Who this helps: Patients recovering from COVID-19 with diaphragm issues.

Plain English
The American Society of Clinical Oncology studied how the COVID-19 pandemic changed how cancer care and clinical research were delivered and made recommendations for improvement. They found that the pandemic highlighted the need for clinical research to be more accessible and equitable, and they suggested five key goals, such as making trials easier to join and ensuring healthcare providers have necessary resources. These changes are important because they aim to enhance patient safety and the quality of cancer care in the future. Who this helps: This benefits patients and healthcare providers.

Plain English
This study looked at how clinical trial site assessments are done to determine if they can effectively conduct cancer clinical trials. Researchers found that the current process is expensive and slow, creating unnecessary barriers, and can delay access to new treatments for patients. They recommend simplifying and standardizing these assessments by using technology and reducing the number of questions asked, which can help more patients get into trials faster. Who this helps: Patients needing access to new cancer treatments.

Plain English
This study looked at whether MRI scans can reliably be used to calculate the Spinal Instability Neoplastic Score (SINS) for patients with metastatic spinal cord compression. Researchers analyzed data from 100 patients, finding that MRI scores tended to be slightly higher compared to CT scan scores, with differences ranging from -0.11 to -0.37. This matters because using the wrong score could affect treatment decisions, potentially leading to inadequate care for patients. Who this helps: This helps patients with metastatic spinal cord compression and their doctors.

Plain English
This study explored how adenosine, a small molecule in the body, affects the behavior of fibroblasts, which are cells that often play a role in tumor growth. Researchers found that adenosine reduces the effects of transforming growth factor beta (TGFβ) on fibroblasts, specifically lowering certain proteins related to their movement and contractility. This is important because understanding how adenosine impacts fibroblast functions could lead to new ways to combat cancer progression and improve patient outcomes. Who this helps: This benefits cancer patients by providing new insights for treatments that target tumor growth.

Plain English
This study looked at how to effectively deliver radiation therapy for prostate cancer in patients who have both hips replaced with prosthetics. Researchers found that all common radiation techniques can still be safely used, with only small increases in radiation dose to nearby organs such as the rectum and bladder. For example, the radiation dose to the rectum increased by up to 9.1% in some cases, but the planning techniques maintained safety standards overall, showing it is possible to avoid significant harm. Who this helps: Patients with prostate cancer who also have hip replacements.

Plain English
This study explores a method to turn non-crystal silicon into crystal silicon using a special laser and a thin layer of molybdenum, without melting anything. The researchers found that by adjusting the laser's intensity, they could create crystals with different sizes, leading to increased electrical conductivity. Specifically, they achieved this crystallization process at temperatures around 700 Kelvin, which is much lower than the melting point of silicon. Who this helps: This benefits manufacturers of electronic devices who need high-quality silicon for better performance.

Plain English
This study looked at how the tissue in the knee joints of people with osteoarthritis (OA) varies based on whether they experience pain. Researchers found that tissue from painful areas had different types of cells called fibroblasts compared to non-painful areas. Specifically, they discovered that in patients with early OA, the fibroblasts at painful sites were better at promoting inflammation and nerve growth, which likely contributes to pain. Who this helps: This research benefits patients with knee osteoarthritis by potentially guiding new pain relief treatments.

Plain English
This study explored a new method using Bayesian analysis to improve the accuracy of diagnoses in electronic health records (EHRs), which often miss or under-report certain health conditions. Researchers found that using Bayesian methods led to better estimates of health conditions, particularly in synthetic data where diagnoses were under-reported; for instance, these estimates were much closer to actual values when prior information was included. However, in actual patient data from UK primary care, while Bayesian methods improved parameter estimates, they didn't enhance classification accuracy compared to standard methods. Who this helps: This benefits researchers and healthcare providers by providing better tools for understanding and addressing missing health condition data.

Plain English
The research studied how the COVID-19 pandemic affected cancer clinical trials in early 2020. Out of 32 respondents, many reported they had to stop or limit patient screenings and visits, but most were able to shift to remote care, which they viewed positively. The findings highlight not only the challenges faced, such as staffing issues and difficulties with patient enrollment, but also opportunities to improve trial processes, like fewer in-person visits and more efficient trial designs. Who this helps: Patients and cancer treatment programs.

Plain English
This study looked at how well doctors at a collaborative group were following imaging guidelines for men with newly diagnosed prostate cancer. They found that the Exponentially Weighted Moving Average (EWMA) method was the best way to quickly spot when doctors were ordering too many unnecessary bone scans, detecting changes up to 1.6 times faster than other methods. This is important because ensuring appropriate imaging use can improve patient care and reduce unnecessary healthcare costs. Who this helps: This helps patients and doctors by improving the quality of prostate cancer diagnosis and treatment.

Plain English
The study looked at how well the training for Good Clinical Practice (GCP) prepares clinical trial researchers to conduct their work effectively. Researchers interviewed 13 clinical investigators and 10 research sponsors and found that while GCP training covers important tasks like obtaining informed consent and ensuring participant safety, there are significant issues with the training format, including repetitive content and a lack of engagement. The study highlights that to improve trial quality, GCP training needs to be more practical and relevant to real-world scenarios. Who this helps: This benefits clinical investigators and patients involved in clinical trials.

Plain English
This study examined how different pain relief medications used during hip surgery affect the health of bone cells called osteoblasts in patients with hip osteoarthritis (OA). Researchers found that these pain relievers, especially Bupivacaine, reduced the viability and function of these cells, with significant harm noted even 7 days after treatment. This matters because maintaining healthy bone cells is crucial for recovery and overall joint health. Who this helps: This information benefits patients with hip osteoarthritis and their doctors by highlighting the potential risks of certain pain relief medications.

Plain English
This study looked at a new tool developed by ASCO to help doctors report serious adverse events (SAEs) accurately when they occur during clinical drug trials. Though the tool did not significantly improve the identification of whether an event was serious, it did make it easier for doctors to correctly link events to the investigational drugs—showing a three and a half times greater accuracy in attribution (an odds ratio of 3.60). This is important because accurate reporting can enhance drug safety monitoring and decrease unnecessary paperwork for researchers. Who this helps: This benefits patients and researchers by improving drug safety reporting.

Plain English
This study looked at how to better detect dementia in older adults who haven't been diagnosed yet. Researchers analyzed health records of over 93,000 patients and found that using machine learning, they could identify signs of dementia in people who were previously overlooked; their model achieved an accuracy of 74%. This is important because early detection can lead to timely care for patients, improving their quality of life. Who this helps: This helps patients and doctors by promoting earlier diagnosis and treatment of dementia.

Plain English
This review examined the use of tests that analyze circulating tumor DNA (ctDNA) in cancer patients. It looked at 1,338 studies and found that while some ctDNA tests are useful for certain advanced cancers, most lack solid evidence to support their reliability in general, especially for early-stage cancer and routine monitoring. This research matters because it highlights the need for using tumor tissue tests alongside ctDNA tests to get accurate results and suggests that more reliable tools and guidelines are necessary as research progresses. Who this helps: This helps doctors and patients who are navigating cancer treatment options.

Plain English
This study looked at tests that analyze circulating tumor DNA (ctDNA) in cancer patients to see how reliable and helpful they are for diagnosing and monitoring various cancers. Out of 1,338 sources reviewed, only 77 were found to provide useful information, revealing that while some ctDNA tests work well for advanced cancers, many do not show clear benefits for other situations, such as early-stage cancer or monitoring treatment. This matters because it highlights the need for further research and careful use of ctDNA tests to ensure they are truly effective and accurate. Who this helps: This helps patients and doctors by guiding them on when ctDNA tests may be beneficial.

Plain English
This study focused on a 41-year-old woman with a type of kidney tumor called angiomyolipoma that was causing internal bleeding. The doctors found a complex blood vessel issue, known as arteriovenous shunting, which complicated treatment. They successfully treated the bleeding by first using larger materials to slow the blood flow, followed by a more targeted treatment that used a special substance to effectively block the problem permanently. Who this helps: This benefits patients with kidney tumors and their doctors by providing a new approach to treat complicated cases.

Plain English
This study looked at a protein called B7-H3 and its relationship with the progression and outcomes of prostate cancer in 2,781 patients. Researchers found that higher levels of B7-H3 were linked to more aggressive cancer stages and worse survival rates, with the data showing a significant association (P<0.001 for Gleason score and tumor stage). Understanding how B7-H3 interacts with cancer could help develop new treatments for prostate cancer patients. Who this helps: This helps prostate cancer patients and doctors managing their treatment.

Plain English
This study focused on improving how doctors use imaging tests, like bone scans and CT scans, for patients newly diagnosed with prostate cancer. After implementing specific criteria for when these tests are necessary, unnecessary bone scans dropped from 11% to 6.5% and CT scans from 14.7% to 7.7%. This change is important because it helps ensure that patients only receive the imaging they truly need, reducing exposure to unnecessary procedures. Who this helps: This helps prostate cancer patients by minimizing unnecessary tests and associated risks.

Plain English
This study looked at how to improve the billing process for clinical trials, which can be confusing and burdensome for research sites. Researchers found that creating a centralized analysis of coverage requirements before starting trials could help streamline the process. This can reduce financial risks, speed up the start of trials, and ultimately make it easier for patients to participate in lifesaving cancer research. Who this helps: Patients seeking new treatment options in clinical trials.

Plain English
This study focused on creating a web-based system to collect feedback from patients after they underwent radical prostatectomy, a surgery for prostate cancer. Among 773 eligible patients, 688 completed pre-surgery surveys, with most patients showing a decline in urinary and erection function after the surgery; average urinary function scores dropped from 18.3 before surgery to 14.3 at three months, while erection scores fell from 18.7 to 7.3. This system allows for better tracking of patient recovery and highlights areas where improvements can be made, ultimately aiming to enhance the quality of care across multiple medical practices. Who this helps: This benefits patients recovering from prostate surgery and their doctors.

Plain English
Researchers studied the heart health of patients who have undergone hematopoietic stem cell transplant (HSCT) and found they are at least four times more likely to develop heart disease compared to the general population. These patients need thorough testing for heart-related health issues before and after their transplant, especially if they already have risk factors like diabetes or high blood pressure. This is important because early detection and treatment can significantly improve their heart health and overall quality of life. Who this helps: This helps HSCT survivors and their doctors by ensuring better heart care for these patients.

Plain English
This study looked at how much work research staff at hospitals and clinics handle while running clinical trials, especially when balancing patient care. Researchers created a tool to help measure and understand this workload better. They found that staff working with patients currently in treatment had higher workload scores compared to those with patients just in follow-up care, and trials funded by industry had the highest workload scores overall. This is important because it helps research managers allocate staff more effectively, ensuring trials run smoothly and comply with regulations. Who this helps: This benefits research staff and managers in community-based medical programs.

Plain English
This study looked at whether patients with heart function issues (specifically, those with a heart pumping efficiency of less than 50%) can safely undergo bone marrow transplants. Researchers compared 49 such patients to 49 others with normal heart function and found similar rates of treatment-related complications and survival after two years—53% for those with systolic dysfunction versus 61% for those with normal function. This is important because it indicates that people with mild heart issues can still receive potentially life-saving treatments without significantly higher risks. Who this helps: This helps patients with borderline heart issues who need stem cell transplants and their doctors.

Plain English
This study looked at how well a specific statistical technique called Gaussian process logistic regression (GP-LR) can classify brain scans of people with Alzheimer's disease (AD) and mild cognitive impairment (a-MCI). The researchers found that this method correctly identified healthy individuals from those with a-MCI 75% of the time, and it accurately distinguished between individuals with a-MCI and those with Alzheimer's disease 97% of the time. This is important because it may lead to more reliable tools for diagnosing these conditions based on brain scans. Who this helps: Patients and doctors working with Alzheimer's and cognitive impairment diagnoses.

Plain English
This study looked at how pancreatic beta cells react to certain inflammatory signals that can harm them. Researchers found almost 97,000 regions in the cells where changes occurred in gene regulation, with a notable 3,590 new regulatory areas formed in response to inflammation within just three hours, and these changes lasted for days. The findings indicate that targeting a specific protein involved in this process could help protect beta cells from damage; however, some methods tested showed risks, like cell death, over longer periods. Who this helps: This research benefits patients with diabetes by potentially guiding treatments to protect insulin-producing cells.

Plain English
This study looked at a young man with disseminated tuberculosis (TB) and tuberculous meningitis, who was experiencing confusion and had signs of TB in his lungs. Testing confirmed he had a serious infection caused by the TB bacteria, despite living in an area where TB is uncommon. The findings underscore the need for doctors to think about TB in patients with certain risk factors, even if they live in places where the disease is not widely seen. Who this helps: Patients who may have TB, especially those with risk factors like alcohol abuse.